Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R21) | Apply Online

Opportunity Summary:

The NIH grant opportunity titled "Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R21)" (Funding Opportunity Number PA-14-013) is a discretionary research grant that focuses on moving beyond gene discovery into the harder, mechanistic work of proving what genetic and genomic findings actually do in the biology of addiction. The announcement is rooted in a common bottleneck in modern addiction science: large-scale genetic and genomic studies can flag candidate genes, variants, regulatory regions, epigenetic marks, or non-coding RNA signals linked to substance use and addiction-related traits, but those statistical or correlative signals do not automatically reveal which findings are truly causal, how they act in relevant cells and circuits, or what molecular pathways they influence. This FOA is designed to support early-stage, exploratory projects that directly test function and mechanism rather than stopping at association.

The scientific scope centers on two complementary research directions. First, the FOA encourages functional validation, meaning experimental work that determines whether a nominated candidate gene, DNA variant, epigenetic feature (such as DNA methylation or chromatin state), or non-coding RNA (for example microRNAs or long non-coding RNAs) has an authentic and biologically meaningful role in addictive processes. In practice, this is about separating true drivers from passenger signals by using functional genomics and related approaches to test whether manipulating the candidate feature changes addiction-relevant phenotypes, molecular readouts, or cellular behaviors in appropriate experimental systems. Second, it supports deeper mechanistic elucidation of the molecular pathways and processes modulated by these candidates, with special emphasis on genes or regulatory elements whose roles in addiction were not anticipated based on prior biology. That point is important because genetic studies often implicate genes outside the "usual suspects" (classic neurotransmitter targets, for example), and the FOA explicitly welcomes work that traces unexpected hits into coherent pathways, networks, and biological processes that can reshape the field's understanding of addiction mechanisms.

The activity mechanism is an R21, which typically supports developmental, high-impact projects that generate decisive functional evidence or open a new mechanistic direction. The award ceiling listed is $200,000, and there is no cost sharing or matching requirement. The program sits within the NIH mission space and is aligned with CFDA 93.279 (Drug Abuse and Addiction Research Programs), signaling its relevance to substance use disorder biology and addiction neuroscience broadly, rather than a narrow focus on any single drug class. While the FOA text provided emphasizes "basic functional genetic and genomic research," the framing clearly prioritizes experiments that connect genotype or regulatory state to functional consequences in biological systems relevant to addictive processes.

Eligibility is broad and includes many organization types across the public, private, nonprofit, academic, and governmental spectrum. Eligible applicants include for-profit organizations (including small businesses and other for-profits), nonprofit organizations with or without 501(c)(3) status, public and state-controlled institutions of higher education, private institutions of higher education, and a wide range of government entities (state governments, county governments, city or township governments, special district governments, independent school districts, and public or Indian housing authorities). The FOA also lists multiple categories of institutions and organizations often highlighted in NIH eligibility language, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based and community-based organizations. Notably, non-U.S. entities are eligible: foreign organizations and foreign institutions can apply, non-U.S. components of U.S. organizations are eligible, and foreign components as defined by the NIH Grants Policy Statement are allowed. That makes the competition open to international teams when the science is compelling and appropriately justified.

In terms of timing and administrative details, the FOA was posted and created on December 5, 2013, with an original and current closing date listed as January 7, 2017, and an archive date of February 7, 2017. Those dates indicate the opportunity is archived rather than currently open, but the summary still captures the program’s intent and structure for anyone looking to understand what NIH was seeking under PA-14-013 or to model a future application to a similar reissued announcement. The administering agency is the National Institutes of Health, and the full announcement was made available through the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PA-14-013.html. For access or technical issues, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Overall, this R21 opportunity was aimed at accelerating the transition from "we found an association" to "we understand the function," by funding targeted, experimentally grounded studies that validate addiction-relevant genetic and genomic candidates and map the downstream molecular pathways they control. The emphasis on epigenetics and non-coding RNAs reflects a recognition that addiction risk and progression are not explained by coding variants alone, and that regulatory layers can provide both mechanistic explanations and, potentially, more precise intervention points once causal roles are established.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Summer Undergraduate Research Fellowship (SURF) Program

Previous opportunity: Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 14 013

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 14 013) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 14 013", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.